Inovio Pharmaceuticals (NASDAQ:INO) Rating Increased to Sell at StockNews.com
StockNews.com upgraded shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) to a sell rating in a report published on Friday. Other research analysts have also issued research reports about the company. HC Wainwright restated a “neutral” rating and set a $3.00 price objective on shares of Inovio Pharmaceuticals in a research report on Wednesday. JMP […]
StockNews.com upgraded shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) to a sell rating in a report published on Friday. Other research analysts have also issued research reports about the company. HC Wainwright restated a “neutral” rating and set a $3.00 price objective on shares of Inovio Pharmaceuticals in a research report on Wednesday. JMP […]
